Three years of COVID-19 pandemic: comparative analysis of incidence, lethality and mortality among the States of the South Region of Brazil

Authors

  • Silvana de Azevedo Brito Programa de Pós-Graduação em Ciências da Saúde, Centro Universitário FMABC - Santo André, São Paulo, Brasil; Laboratório de Delineamento de Estudo e Escrita Científica, Centro Universitário FMABC - Santo André, São Paulo, Brasil;
  • Luiz Carlos de Abreu Programa de Pós-Graduação em Ciências da Saúde, Centro Universitário FMABC - Santo André, São Paulo, Brasil; Laboratório de Delineamento de Estudo e Escrita Científica, Centro Universitário FMABC - Santo André, São Paulo, Brasil; Professor Titular. Programa de Pós-graduação em Saúde Coletiva, Universidade Federal do Espírito Santo, Brasil;
  • Daniel Alvarez Estrada Programa de Pós-Graduação em Ciências da Saúde, Centro Universitário FMABC - Santo André, São Paulo, Brasil; Laboratório de Delineamento de Estudo e Escrita Científica, Centro Universitário FMABC - Santo André, São Paulo, Brasil
  • Marcelo Ferraz Campos Professor Titular. Departamento de Educação Integrada em Saúde. Programa de Pós-graduação em Saúde Coletiva, Universidade Federal do Espírito Santo, Brasil;
  • Matheus Paiva Emidio Cavalcanti Laboratório de Delineamento de Estudo e Escrita Científica, Centro Universitário FMABC - Santo André, São Paulo, Brasil;
  • Alzira Alves de Siqueira Carvalho Programa de Pós-Graduação em Ciências da Saúde, Centro Universitário FMABC - Santo André, São Paulo, Brasil

DOI:

https://doi.org/10.36311/jhgd.v33.15285

Keywords:

COVID-19, incidence, lethality, mortality, trend

Abstract

Introduction: in Brazil, the first case of COVID-19 was confirmed on February 26, 2020 As of March 17, 2023, the Ministry of Health recorded 699,634 deaths from COVID-19, with a fatality rate of 1.9%. The impact of the COVID-19 pandemic in Brazil in socioeconomic and health system spheres and a reflection of major regional differences.

Objective: to analyze mortality, incidence and lethality due to COVID-19 in the states of Paraná and Santa Catarina, southern Brazil.

Methods: this is an ecological time series study using official Brazilian secondary data for cases and deaths from COVID-19. The data were extracted from the panel of the State Department of Health of the states of Santa Catarina and Paraná. For trend analysis, time series were developed using the Prais-Winsten regression model. Statistical analyzes were performed using STATA 14.0 software (College Station, TX, USA, 2013).

Results: in the analysis of rates in the total period analyzed, the trends for mortality, lethality and incidence in the state of Santa Catarina are decreasing, decreasing and stationary, respectively. In the state of Paraná, rates in the total period showed a stationary, decreasing and increasing trend for mortality, lethality and incidence, respectively.

Conclusion: COVID-19 had a devastating effect on the states of Santa Catarina and Paraná. Both states suffered from the progress of the COVID-19 pandemic, with higher lethality and mortality rates being observed in the state of Paraná, while Santa Catarina had a higher incidence rate over the three years it was in effect. COVID-19 pandemic.

Downloads

Download data is not yet available.

References

Rovetta A, Bhagavathula AS. The Impact of COVID-19 on Mortality in Italy: Retrospective Analysis of Epidemiological Trends. JMIR Public Health Surveill. 2022; 8: e36022. DOI: 10.2196/36022

World Health Organization (WHO). Coronavirus (COVID-19) Dashboard. [(accessed on 15 December 2022)]. Available online: https://covid19.who.int.

OPAS. Histórico da pandemia de COVID-19. Organização Pan-americana da Saúde (OPAS) [Internet]. Available From: https://www.paho.org/pt/covid19/historico-da-pandemia-covid-19

Li Q, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020; 382(13): 1199-1207.

Muralidar S, et al. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie. 2020;179:85-100.

Chavda VP, Vuppu S, Mishra T, Kamaraj S, Patel AB, Sharma N, Chen Z-S. Recent Review of COVID-19 Management: Diagnosis, Treatment and Vaccination. Pharmacol Rep. 2022; 74: 1120–1148Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. 2020; 41(12): 1100-1115.

Monpara JD, Sodha SJ, Gupta PK. COVID-19 Associated Complications and Potential Therapeutic Targets. Eur J Pharmacol. 2020;886:173548. doi: 10.1016/j.ejphar.2020.

Iser BPM, et al. Definição de caso suspeito da COVID-19: uma revisão narrativa dos sinais e sintomas mais frequentes entre os casos confirmados. Epidemiologia e Serviços de Saúde. 2020;29.

Lopes LFD, et al. Descrição do perfil epidemiológico da Covid-19 na Região Sul do Brasil. Hygeia-Revista Brasileira de Geografia Médica e da Saúde. 2020;16:188-198.

IBGE – Instituto Brasileiro de Geografia e Estatística. Censo Brasileiro de 2010. Rio de Janeiro: IBGE, 2012.

Secretaria da Saúde. Estado de Santa Catarina. Painel de casos de Covid-19. Available at: http://www.coronavirus.sc.gov.br/ Accessed on: 17 Jul 2023.

Moura EC, Cortez-Escalante J, Cavalcante FV, Barreto IC de HC, Sanchez MN, Santos LMP. Covid-19: evolução temporal e imunização nas três ondas epidemiológicas, Brasil, 2020–2022. Revista de Saúde Pública 2022;56:105–105. https://doi.org/10.11606/s1518-8787.2022056004907.

Abreu L, Elmusharaf K, Gomes Siqueira CE. A time-series ecological study protocol to analyze trends of incidence, mortality, lethality of COVID-19 in Brazil. J Hum Growth Dev. 2021; 31(3).

Antunes JL, Cardoso MR. Uso da análise de séries temporais em estudos epidemiológicos. Epidemiol Serv Saude. 2015; 24: 565-576.

Secretaria da Saúde. Estado do Paraná. Coronavírus - COVID-19.

Rambotti S, Wolski C, Anderson KF. It Didn’t Go Away: The Political and Social Determinants of COVID-19 Mortality Rates across Counties in the United States. COVID. 2023; 3(3): 370-380.

Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). J Gen Intern Med. Mar 2020.

Barbosa Filho VC, et al. Effect of a multicomponent intervention on lifestyle factors among Brazilian adolescents from low human development index areas: a cluster-randomized controlled trial. Int J Environ Res Public Health. 2019; 16(2): 267.

dos Santos Alves JC, et al. Did the COVID-19 Pandemic Disproportionately Affect the Most Socioeconomically Vulnerable Areas of Brazil? COVID. 2023; 3(6): 924-936.

IPARDES - Instituto Paranaense de Desenvolvimento Econômico e Social [Internet]. [citado 14 de julho de 2023]. Distribuição do PIB paranaense é a mais equilibrada da série histórica. 2022. Available at: https://www.ipardes.pr.gov.br/Noticia/Distribuicao-do-PIB-paranaense-e-mais-equilibrada-da-serie-historica

SIDEMS. Índice de Gini dos municípios catarinenses. Sistema de Indicadores de Desenvolvimento Municipal Sustentável. 2022. Available at: https://indicadores.fecam.org.br/indice/estadual/ano/2022/codIndicador/2305

Freitas CM, Silva IV, Cidade NC. COVID-19 as a global disaster: challenges to risk governance and social vulnerability in Brazil. Ambiente & Sociedade. 2020; 23: e0115.

Freitas CM, et al. Covid-19 no Brasil: cenários epidemiológicos e vigilância em saúde. Série Informação para ação na Covid-19| Fiocruz, 2021.

Daboin BEG, et al. Deciphering Multifactorial Correlations of COVID-19 Incidence and Mortality in the Brazilian Amazon Basin. Int J Environ Res Public Health. 2022; 19(3): 1153.

Lopes LFD, et al. Descrição do perfil epidemiológico da Covid-19 na Região Sul do Brasil. Hygeia-Revista Brasileira de Geografia Médica e da Saúde. 2020; 16: 188-198.

Freitas CM, Barcellos C, Villela DAM. Covid-19 no Brasil: cenários epidemiológicos e vigilância em saúde. Série Informação para ação na Covid-19| Fiocruz. 2021.

Callaway E. COVID’s future: mini-waves rather than seasonal surges. Nature. 2023.

Parodi SM, Liu VX. From Containment to Mitigation of COVID-19 in the US. JAMA. 2020; 323: 1441. DOI: 10.1001/jama.2020.3882.

Mattiuzzi C, Lippi G. Primary COVID-19 Vaccine Cycle and Booster Doses Efficacy: Analysis of Italian Nationwide Vaccination Campaign. Eur J Public Health. 2022; 32: 328–330. DOI: 10.1093/eurpub/ckab220.

Bollyky TJ, Gostin LO, Hamburg MA. The Equitable Distribution of COVID-19 Therapeutics and Vaccines. JAMA. 2020; 323: 2462. DOI: 10.1001/jama.2020.6641

Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z, Li X, Xu W, Mesa-Eguiagaray I, Rostron J, et al. Effectiveness of Public Health Measures in Reducing the Incidence of COVID-19, SARS-CoV-2 Transmission, and COVID-19 Mortality: Systematic Review and Meta-Analysis. BMJ. 2021; 375: e068302. DOI: 10.1136/bmj-2021-068302

Mohseni Afshar Z, Hosseinzadeh R, Barary M, Ebrahimpour S, Alijanpour A, Sayad B, et al. Challenges posed by COVID-19 in cancer patients: A narrative review. Cancer Med. 2022; 11: 1119–35.

Calabrò GE, Pappalardo C, D’Ambrosio F, Vece M, Lupi C, Lontano A, Di Russo M, Ricciardi R, De Waure C. The Impact of Vaccination on COVID-19 Burden of Disease in the Adult and Elderly Population: A Systematic Review of Italian Evidence. Vaccines (Basel). 2023 May 22; 11(5): 1011.

Published

2023-12-01

Issue

Section

ORIGINAL ARTICLES